Sch 21420

Known as: Sch-21420 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2007
024619782007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1995
Review
1995
Isepamicin (formerly SCH 21420 or 1-N-HAPA-gentamicin B) is a novel broad-spectrum aminoglycoside which possesses a high level of… (More)
Is this relevant?
1995
1995
The narrow therapeutic/toxic ratio of existing aminoglycosides has led to a search for safer drugs of this class. Isepamicin is a… (More)
Is this relevant?
1993
1993
The in vitro activities of various quinolones, two new aminoglycosides, a new cephamycin analog (cefmetazole) and a new… (More)
Is this relevant?
1980
1980
Disk susceptibility tests with two structurally related aminoglycosides (amikacin and Sch 21420) were evaluated. Tests with 10… (More)
  • figure 1
  • figure 2
  • table 2
Is this relevant?
1979
1979
The nephrotoxic potentials of the new aminoglycoside SCH 21420 and amikacin were compared in a rat model. Groups of rats received… (More)
  • figure 1
  • table 1
Is this relevant?
1978
1978
The minimal inhibitory concentration of Sch-21420 closely paralleled amikacin for 125 strains of aerobic gram-negative bacilli… (More)
Is this relevant?
1978
1978
Sch 21420, the 1-N-HAPA derivative of gentamicin B, has been compared to gentamicin, tobramycin and amikacin in a variety of in… (More)
Is this relevant?
1978
1978
In vitro tests were performed with Sch 21420 and Sch 22591 to determine (i) their activity in comparison to six other… (More)
Is this relevant?
1978
1978
The activities of Sch 21420 and amikacin were compared in vitro against 448 clinical bacterial isolates and against 82 gentamicin… (More)
Is this relevant?
1978
1978
With the increasing prevalence of Gramnegative bacilli resistant to existing aminoglycosides, new semisynthetic aminoglycosides… (More)
  • table 1
  • table 2
Is this relevant?